FISHKILL, N.Y., Jan. 17, 2012 /PRNewswire/ -- Nano Mask, Inc. (NMI) (Pink Sheets: NANM), a healthcare product development and distribution company focused on emergency and critical care as well as infection control markets, today announced that it has opened a sales, marketing and distribution office in Riyadh, Saudi Arabia to service its customers in the Middle East and to tap into the strong demand for its products in the region. Mr. David Willoughby, NMI's VP, Sales and Marketing, will be stationed in Riyadh over the next 6 to 12 months in order to work closely with NMI's Saudi Arabian partners in developing sales and distribution channels in the region.
NMI previously announced a distribution agreement with a Saudi Arabia-based medical products distributor which will represent NMI's product line on an exclusive basis to: The Kingdom of Saudi Arabia, United Arab Emirates (UAE), Kuwait, Egypt, Morocco, Oman, Algeria, Qatar, Jordan, Bahrain, Sudan, Yemen Lebanon, Yemen and Tunisia.
The Saudi Arabian medical products distributor, having already placed significant orders with NMI, has agreed to order a minimum of more than $2 million over the next four years. The products that will be marketed and sold in the Territory are: NMI's emergency life support and respiratory products (utilizing the company's industry leading patented 2H Filtration Technology), antimicrobial hospital barrier products and NMI's proprietary line of bacteria free enzymatic medical detergents specially formulated for instrument reprocessing.
Separately, NMI announced that it will be exhibiting, in conjunction with its Saudi Arabian partners, its products at Arab Health Trade Show in Dubai, UAE from 1-23-2012 thru 1-26-2012 (http://www.arabhealthonline.com/home/). This is a major event in the Middle Eastern healthcare market and will provide an excellent showcase for NMI products.
About Nano Mask, Inc.
NMI is the inventor of 2H Technology, an advanced dual filtration system which is designed to remove infectious bacteria and virus from airflow systems at extremely high levels of efficiency. In addition to the company's advanced filtration materials and products, NMI also markets a line of innovative infection control products which range from proprietary enzymatic instrument reprocessing solutions to innovative antimicrobial textiles in the United States and internationally.
This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. Specifically, any unforeseen delays in manufacturing and distribution may affect sales of NMI products. NMI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.
For further information:
SOURCE Nano Mask, Inc.